• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管生成素样蛋白4:血管内脂肪分解调节的新模式。

ANGPTL4: a new mode in the regulation of intravascular lipolysis.

作者信息

Ploug Michael

机构信息

Finsen Laboratory, Rigshospitalet.

Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark.

出版信息

Curr Opin Lipidol. 2022 Apr 1;33(2):112-119. doi: 10.1097/MOL.0000000000000800.

DOI:10.1097/MOL.0000000000000800
PMID:34860701
Abstract

PURPOSE OF REVIEW

Lipoprotein lipase (LPL) is the rate-limiting enzyme for intravascular processing of circulating triglyceride-rich lipoproteins (TRLs). One emerging strategy for therapeutic lowering of plasma triglyceride levels aims at increasing the longevity of LPL activity by attenuating its inhibition from angiopoietin-like proteins (ANGPTL) 3, 4 and 8. This mini-review focuses on recent insights into the molecular mechanisms underpinning the regulation of LPL activity in the intravascular unit by ANGPTLs with special emphasis on ANGPTL4.

RECENT FINDINGS

Our knowledge on the molecular interplays between LPL, its endothelial transporter GPIHBP1, and its inhibitor(s) ANGPTL4, ANGPTL3 and ANGPTL8 have advanced considerably in the last 2 years and provides an outlined on how these proteins regulate the activity and compartmentalization of LPL. A decisive determinant instigating this control is the inherent protein instability of LPL at normal body temperature, a property that is reciprocally impacted by the binding of GPIHBP1 and ANGPTLs. Additional layers in this complex LPL regulation is provided by the different modulation of ANGPTL4 and ANGPTL3 activities by ANGPTL8 and the inhibition of ANGPTL3/8 complexes by apolipoprotein A5 (APOA5).

SUMMARY

Posttranslational regulation of LPL activity in the intravascular space is essential for the differential partitioning of TRLs across tissues and their lipolytic processing in response to nutritional cues.

摘要

综述目的

脂蛋白脂肪酶(LPL)是循环中富含甘油三酯的脂蛋白(TRL)血管内代谢的限速酶。一种新出现的降低血浆甘油三酯水平的治疗策略旨在通过减弱血管生成素样蛋白(ANGPTL)3、4和8对LPL活性的抑制作用来延长LPL活性的持续时间。本综述聚焦于ANGPTL对血管内单元中LPL活性调控的分子机制的最新见解,特别强调ANGPTL4。

最新发现

在过去两年中,我们对LPL、其内皮转运蛋白GPIHBP1及其抑制剂ANGPTL4、ANGPTL3和ANGPTL8之间分子相互作用的认识有了显著进展,并概述了这些蛋白如何调节LPL的活性和分布。促使这种调控的一个决定性因素是LPL在正常体温下固有的蛋白质不稳定性,这一特性会受到GPIHBP1和ANGPTL结合的反向影响。ANGPTL8对ANGPTL4和ANGPTL3活性的不同调节以及载脂蛋白A5(APOA5)对ANGPTL3/8复合物的抑制为这种复杂的LPL调节增加了额外层次。

总结

血管内空间中LPL活性的翻译后调控对于TRL在不同组织间的分配及其响应营养信号的脂解过程至关重要。

相似文献

1
ANGPTL4: a new mode in the regulation of intravascular lipolysis.血管生成素样蛋白4:血管内脂肪分解调节的新模式。
Curr Opin Lipidol. 2022 Apr 1;33(2):112-119. doi: 10.1097/MOL.0000000000000800.
2
Genetic Mimicry Analysis Reveals the Specific Lipases Targeted by the ANGPTL3-ANGPTL8 Complex and ANGPTL4.遗传模拟分析揭示了 ANGPTL3-ANGPTL8 复合物和 ANGPTL4 靶向的特定脂肪酶。
J Lipid Res. 2023 Jan;64(1):100313. doi: 10.1016/j.jlr.2022.100313. Epub 2022 Nov 11.
3
Angiopoietin-like protein 8: a multifaceted protein instrumental in regulating triglyceride metabolism.血管生成素样蛋白 8:一种调节甘油三酯代谢的多功能蛋白。
Curr Opin Lipidol. 2024 Apr 1;35(2):58-65. doi: 10.1097/MOL.0000000000000910. Epub 2023 Nov 14.
4
Regulation of lipoprotein metabolism by ANGPTL3, ANGPTL4, and ANGPTL8.ANGPTL3、ANGPTL4 和 ANGPTL8 对脂蛋白代谢的调节。
Am J Physiol Endocrinol Metab. 2021 Oct 1;321(4):E493-E508. doi: 10.1152/ajpendo.00195.2021. Epub 2021 Aug 2.
5
GPIHBP1 and ANGPTL4 Utilize Protein Disorder to Orchestrate Order in Plasma Triglyceride Metabolism and Regulate Compartmentalization of LPL Activity.糖基磷脂酰肌醇锚定高密度脂蛋白结合蛋白1(GPIHBP1)和血管生成素样蛋白4(ANGPTL4)利用蛋白质无序化来协调血浆甘油三酯代谢中的有序性并调节脂蛋白脂肪酶(LPL)活性的区室化。
Front Cell Dev Biol. 2021 Jul 15;9:702508. doi: 10.3389/fcell.2021.702508. eCollection 2021.
6
ANGPTL8 promotes the ability of ANGPTL3 to bind and inhibit lipoprotein lipase.ANGPTL8 增强了 ANGPTL3 结合并抑制脂蛋白脂肪酶的能力。
Mol Metab. 2017 Oct;6(10):1137-1149. doi: 10.1016/j.molmet.2017.06.014. Epub 2017 Jun 29.
7
On the mechanism of angiopoietin-like protein 8 for control of lipoprotein lipase activity.关于血管生成素样蛋白 8 控制脂蛋白脂肪酶活性的机制。
J Lipid Res. 2019 Apr;60(4):783-793. doi: 10.1194/jlr.M088807. Epub 2019 Jan 27.
8
ApoA5 lowers triglyceride levels via suppression of ANGPTL3/8-mediated LPL inhibition.载脂蛋白 A5 通过抑制 ANGPTL3/8 介导的 LPL 抑制来降低甘油三酯水平。
J Lipid Res. 2021;62:100068. doi: 10.1016/j.jlr.2021.100068. Epub 2021 Mar 21.
9
An anti-ANGPTL3/8 antibody decreases circulating triglycerides by binding to a LPL-inhibitory leucine zipper-like motif.一种抗 ANGPTL3/8 抗体通过与 LPL 抑制性亮氨酸拉链样基序结合来降低循环中的甘油三酯。
J Lipid Res. 2022 May;63(5):100198. doi: 10.1016/j.jlr.2022.100198. Epub 2022 Mar 17.
10
Angiopoietin-like protein 8 differentially regulates ANGPTL3 and ANGPTL4 during postprandial partitioning of fatty acids.血管生成素样蛋白 8 在脂肪酸餐后分配过程中差异调节 ANGPTL3 和 ANGPTL4。
J Lipid Res. 2020 Aug;61(8):1203-1220. doi: 10.1194/jlr.RA120000781. Epub 2020 Jun 2.

引用本文的文献

1
ANGPTL4: A Comprehensive Review of 25 Years of Research.血管生成素样蛋白4:25年研究综述
Cancers (Basel). 2025 Jul 16;17(14):2364. doi: 10.3390/cancers17142364.
2
Absence of the intracellular lipolytic inhibitor G0S2 enhances intravascular triglyceride clearance and abolishes diet-induced hypertriglyceridemia.细胞内脂解抑制剂G0S2的缺失增强了血管内甘油三酯的清除,并消除了饮食诱导的高甘油三酯血症。
J Clin Invest. 2025 Mar 18;135(10). doi: 10.1172/JCI181754. eCollection 2025 May 15.
3
Angiopoietin-like Proteins and Lipoprotein Lipase: The Waltz Partners That Govern Triglyceride-Rich Lipoprotein Metabolism? Impact on Atherogenesis, Dietary Interventions, and Emerging Therapies.
血管生成素样蛋白与脂蛋白脂肪酶:调控富含甘油三酯脂蛋白代谢的华尔兹舞伴?对动脉粥样硬化形成、饮食干预及新兴疗法的影响
J Clin Med. 2024 Sep 4;13(17):5229. doi: 10.3390/jcm13175229.
4
A unified model for regulating lipoprotein lipase activity.调控脂蛋白脂肪酶活性的统一模型。
Trends Endocrinol Metab. 2024 Jun;35(6):490-504. doi: 10.1016/j.tem.2024.02.016. Epub 2024 Mar 23.
5
Knockdown of ANGPTL4 inhibits adipogenesis of preadipocyte via autophagy.ANGPTL4 基因敲低通过自噬抑制前体脂肪细胞的脂肪生成。
In Vitro Cell Dev Biol Anim. 2024 Mar;60(3):258-265. doi: 10.1007/s11626-024-00861-y. Epub 2024 Feb 29.
6
ANGPTL4, a direct target of hsa-miR-133a-3p, accelerates lung adenocarcinoma lipid metabolism, proliferation and invasion.ANGPTL4 是 hsa-miR-133a-3p 的直接靶标,可加速肺腺癌的脂质代谢、增殖和侵袭。
Aging (Albany NY). 2023 Dec 29;16(9):8348-8360. doi: 10.18632/aging.205313.
7
ANGPTL4 binds to the leptin receptor to regulate ectopic bone formation.ANGPTL4 与瘦素受体结合以调节异位骨形成。
Proc Natl Acad Sci U S A. 2024 Jan 2;121(1):e2310685120. doi: 10.1073/pnas.2310685120. Epub 2023 Dec 26.
8
Correlation Between the Levels of ANGPTL3, ANGPTL4, ANGPTL8 and Postprandial Triglyceride-Rich Lipoprotein (TRL).血管生成素样蛋白3、血管生成素样蛋白4、血管生成素样蛋白8水平与餐后富含甘油三酯脂蛋白(TRL)之间的相关性
Diabetes Metab Syndr Obes. 2023 Dec 6;16:3979-3993. doi: 10.2147/DMSO.S438757. eCollection 2023.
9
Angiopoietin-like protein 4/8 complex-mediated plasmin generation leads to cleavage of the complex and restoration of LPL activity.血管生成素样蛋白 4/8 复合物介导致纤溶酶生成,导致复合物的裂解和 LPL 活性的恢复。
Proc Natl Acad Sci U S A. 2023 Feb 14;120(7):e2214081120. doi: 10.1073/pnas.2214081120. Epub 2023 Feb 10.
10
Broadening the Scope of Dyslipidemia Therapy by Targeting APOC3 (Apolipoprotein C3) and ANGPTL3 (Angiopoietin-Like Protein 3).通过靶向 APOC3(载脂蛋白 C3)和 ANGPTL3(血管生成素样蛋白 3)拓宽血脂异常治疗范围。
Arterioscler Thromb Vasc Biol. 2023 Mar;43(3):388-398. doi: 10.1161/ATVBAHA.122.317966. Epub 2022 Dec 29.